Benralizumab 30 mg/mL Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 30 mg/mL
Reference Brands: Fasenra (USA/EU)
Category: Respiratory Disorder
Benralizumab is a monoclonal antibody used for the treatment of severe eosinophilic asthma. It works by targeting and binding to the interleukin-5 receptor alpha (IL-5Rα) on eosinophils, leading to their rapid depletion. This helps reduce inflammation in the airways and improves breathing. Benralizumab is administered via subcutaneous injection once every four to eight weeks.
Benralizumab — third party manufacturing & bulk supply
Benralizumab 30 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Benralizumab listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Benralizumab →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Benralizumab is used to treat severe eosinophilic asthma in adults and adolescents, helping to reduce asthma attacks and improve breathing.
Benralizumab is made from a humanized monoclonal antibody that targets the interleukin-5 receptor (IL-5Rα) on eosinophils, leading to their depletion and reducing inflammation in the airways.
The trade name of Benralizumab is Fasenra.
Benralizumab is made by AstraZeneca.
The generic name of the product is Benralizumab.
The brand name of Benralizumab is Fasenra.
Benralizumab is manufactured by AstraZeneca in the United States and the United Kingdom.
Related Products
Salmeterol Xinafoate
Strength:
25 µg, 50 µg
Form: Inhalation
Reference Brands: Serevent (USA/LATAM/EU)
View Details
Formoterol Fumarate
Strength:
12 µg
Form: Inhalation
Reference Brands: Foradil (USA/LATAM), Oxis (India)
View Details
Ethionamide
Strength:
250 mg
Form: Tablets
Reference Brands: Generic formulations marketed under different names
View Details
Olodaterol
Strength:
2.5 mcg
Form: Inhalation solution
Reference Brands: Striverdi Respimat (USA)
View DetailsQuick Response Guaranteed | Verified Suppliers
